Roche Elecsys Anti-SARS-CoV-2 Antibody Test Goes Live at More than 20 Initial Lab Sites in US
Roche’s (Basel, Switzerland) Elecsys Anti-SARS-CoV-2 antibody test is currently live at more than 20 commercial and hospital lab sites throughout the US, with plans in the next several weeks to increase to more than 200 commercial and hospital lab sites with the ability to perform millions of tests per week. More...28 May 2020
Gilead’s Antiviral Drug Remdesivir Benefits Some Hospitalized COVID-19 Patients in Clinical Trial
Preliminary findings of a clinical trial of Gilead Sciences’ (Foster City, CA, USA) remdesivir in adults hospitalized with COVID-19 support the use of the antiviral drug, although it is unlikely to be sufficient if taken alone. More...28 May 2020
Adaptive COVID-19 Treatment Trial of New Drug Combination Enters Next Stage
The Adaptive COVID-19 Treatment Trial (ACTT), to evaluate treatment options for people hospitalized with severe COVID-19 infection, has entered the next stage and will now study remdesivir in combination with baricitinib or placebo. More...27 May 2020
Merck Announces Acquisition and Collaborations to Combat COVID‑19
Merck (Kenilworth, NJ, USA) has announced three significant scientific initiatives to combat COVID-19: two agreements to develop potential vaccines against SARS-CoV-2, and a research collaboration to advance the development of a novel antiviral candidate. More...27 May 2020
Novavax Initiates Phase 1/2 Clinical Trial of COVID-19 Vaccine
Novavax, Inc. (Gaithersburg, MD, USA) has begun enrollment of the first participants in a Phase 1/2 clinical trial of its coronavirus vaccine candidate, NVX‑CoV2373, a stable, prefusion protein made using its proprietary nanoparticle technology. More...27 May 2020
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Gold Member
X-Ray QA Meter
T3 AD Pro
New
Monitor Cart
Tryten S5
New
Phototherapy Eye Protector
EyeMax2
In Other News
Philips Launches Wireless Wearable Biosensor to Help Monitor COVID-19 Patients
Siemens Begins Shipping COVID-19 Total Antibody Test and Molecular Test Kit Globally
Aalto Bio Launches New Recombinant Eukaryotic SARS-CoV-2, S1-S2 Spike Proteins for COVID-19 Testing
Fulgent Receives FDA Emergency Use Authorization for SARS-CoV-2 RT-PCR Test
'Self-Cleaning' Electric Mask Can Kill Coronavirus Using Phone Charger
Randox Whole Pathogen Molecular Controls for SARS-CoV-2 (COVID-19) Receive CE Marking
CanSino Bio COVID-19 Vaccine Candidate Moves into Phase II After Publishing Promising Phase I Results
Antibody from SARS Survivor Neutralizes SARS-CoV-2 Live Virus Infection of Cells
Seasun Biomaterials Secures FDA Emergency Use Authorization for Second COVID-19 Rapid Detection Kit
Fujifilm to Develop AI-Based Technology for Analysis of Coronavirus-Induced Pneumonia
Unique AI Algorithm Analyzes Chest CT Scans and Patient Data to Rapidly Detect COVID-19
New Mount Sinai Venture to Manufacture and Distribute COVID Antibody Test Kits Globally
AI-Based Drug Discovery Model Hunts for Key Molecule to Block COVID-19
Abbott Wins UK Government Contract to Supply Millions of Laboratory-Based IgG Antibody Tests
Roche Acquires Stratos Genomics to Advance Development of DNA-Based Sequencing for Diagnostic Use
Intelligent Healthcare Robot Aids Early Detection of COVID-19 Symptoms
Scientists Use Virtual Reality to Refine New AI-Generated Drugs for COVID-19
New AI-Driven Tool Mines COVID-19 Research for New Treatments and Vaccine
New Rapid Laser Testing Technology Identifies Coronavirus as Soon as Blood Cells Are Infected
Fibroblast Cell Therapy Achieves COVID-19 Breakthrough in Pre-Clinical Trial Phase
GSK and Mammoth Biosciences to Jointly Develop Handheld, Disposable and Rapid CRISPR-based Test for COVID-19
Enzo Biochem Launches Proprietary Test for Detection of Coronavirus SARS-CoV-2 IgG Antibody
CanSino Biologics and Precision NanoSystems to Co-Develop COVID-19 RNA Vaccine
